Post-earnings recap
Reported
Thu, Feb 1, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Amgen's earnings report showed a miss on EPS, which contributed to a slight decline in stock price by 0.26%. Investors may be concerned about the company's performance amidst challenging market conditions. The lack of revenue data and forward guidance adds uncertainty to the outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.89 | N/A | -7.27% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed a cautious outlook while highlighting their focus on future growth. They did not provide specific guidance for the upcoming quarters.
Management acknowledged the challenging market conditions.
They emphasized their commitment to innovation and pipeline development.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—